Acquisition of a high diversity of bacteria during the Hajj pilgrimage, including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 carbapenemase genes

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 10, 2016, Pages 5942-5948

  Leangapichart, Thongpan ^a   Gautret, Philippe ^a   Griffiths, Karolina ^a   Belhouchat, Khadidja ^a   Memish, Ziad ^b,c   Raoult, Didier ^a   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEMASE; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; OFLOXACIN; RIFAMPICIN; TIMENTIN; TOBRAMYCIN; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE NDM-5, E COLI; OXA-72 CARBAPENEMASE, ACINETOBACTER BAUMANNII;

ACINETOBACTER BAUMANNII; ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLA NDM 5 GENE; BLA OXA 72 GENE; ESCHERICHIA COLI; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; RITUAL; SAUDI ARABIA; THROAT CULTURE; ACINETOBACTER INFECTION; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; FRANCE; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PHARYNX;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FRANCE; GENETIC VARIATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHARYNX; SAUDI ARABIA;

EID: 84992623173     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00669-16     Document Type: Article

References (45)

1. Memish ZA, Zumla A, Alhakeem RF, Assiri A, Turkestani A, Al Harby KD, Alyemni M, Dhafar K, Gautret P, Barbeschi M, McCloskey B, Heymann D, Al Rabeeah AA, Al-Tawfiq JA. 2014. Hajj: infectious disease surveillance and control. Lancet 383:2073-2082. http://dx.doi.org/10.1016/S0140-6736(14)60381-0.
2. Mandourah Y, Al-Radi A, Ocheltree AH, Ocheltree SR, Fowler RA. 2012. Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect Dis 12:117. http://dx.doi.org/10.1186/1471-2334-12-117.
3. Memish ZA, Almasri M, Turkestani A, Al-Shangiti AM, Yezli S. 2014. Etiology of severe community-acquired pneumonia during the 2013 Hajj - part of the MERS-CoV surveillance program. Int J Infect Dis 25: 186-190. http://dx.doi.org/10.1016/j.ijid.2014.06.003.
4. Benkouiten S, Belhouchat K, Drali T, Salez N, Memish ZA, Fournier P, Raoult D, Brouqui P, Parola P, Gautret P, Charrel R, Drali T, Nougairede A, Salez N, Raoult D, Brouqui P, Parola P. 2014. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg Infect Dis 20:1821-1827. http://dx.doi.org/10.3201/eid2011.140600.
5. Hassing RJ, Alsma J, Arcilla MS, van Genderen PJ, Stricker BH, Verbon A. 2015. International travel and acquisition of multidrug-resistant Enterobacteriaceae: a systematic review. Euro Surveill 20(47):pii=30074. http://dx.doi.org/10.2807/1560-7917.ES.2015.20.47.30074.
6. Leangapichart T, Dia NM, Olaitan AO, Gautret P, Brouqui P, Rolain J-M. 2016. Acquisition of extended-spectrum β-lactamases by Escherichia coli and Klebsiella pneumoniae in gut microbiota of pilgrims during the Hajj pilgrimage of 2013. Antimicrob Agents Chemother 60:3222-3226. http://dx.doi.org/10.1128/AAC.02396-15.
7. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2.
8. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. 2011. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 53:49-56. http://dx.doi.org/10.1093/cid/cir273.
9. Olaitan AO, Dia NM, Gautret P, Benkouiten S, Belhouchat K, Drali T, Parola P, Brouqui P, Memish Z, Raoult D, Rolain J-M. 2015. Acquisition of extended-spectrum cephalosporin- and colistin-resistant Salmonella enterica subsp. enterica serotype Newport by pilgrims during Hajj. Int J Antimicrob Agents 45:600-604. http://dx.doi.org/10.1016/j.ijantimicag.2015.01.010.
10. Anstey NM, Currie BJ, Hassell M, Palmer D, Dwyer B, Seifert H. 2002. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol 40:685-686. http://dx.doi.org/10.1128/JCM.40.2.685-686.2002.
11. Seng P, Rolain J-M, Fournier PE, La Scola B, Drancourt M, Raoult D. 2010. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 5:1733-1754. http://dx.doi.org/10.2217/fmb.10.127.
12. Diene SM, Bruder N, Raoult D, Rolain J-M. 2011. Real-time PCR assay allows detection of the New Delhi metallo-β-lactamase (NDM-1)-encoding gene in France. Int J Antimicrob Agents 37:544-546. http://dx.doi.org/10.1016/j.ijantimicag.2011.02.006.
13. Zhou H, Pi BR, Yang Q, Yu YS, Chen YG, Li LJ, Zheng SS. 2007. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1-blaOXA-23 genes in a Chinese hospital. J Med Microbiol 56:1076-1080. http://dx.doi.org/10.1099/jmm.0.47206-0.
14. Dallenne C, da Costa A, Decré D, Favier C, Arlet G. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65:490-495. http://dx.doi.org/10.1093/jac/dkp498.
15. Pasterán F, Rapoport M, Petroni A, Faccone D, Corso A, Galas M, Vázquez M, Procopio A, Tokumoto M, Cagnoni V. 2006. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 50:3222-3224. http://dx.doi.org/10.1128/AAC.00284-06.
16. Roschanski N, Fischer J, Guerra B, Roesler U. 2014. Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae. PLoS One 9:e100956. http://dx.doi.org/10.1371/journal.pone.0100956.
17. Kempf M, Rolain J-M, Diatta G, Azza S, Samb B, Mediannikov O, Gassama Sow A, Diene SM, Fenollar F, Raoult D. 2012. Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs. PLoS One 7:e39495. http://dx.doi.org/10.1371/journal.pone.0039495.
18. Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M, Landraud L, Rolain J-M. 2014. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother 58:212-220. http://dx.doi.org/10.1128/AAC.01310-13.
19. Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O. 2013. Antibiotic resistance- the need for global solutions. Lancet Infect Dis 13:1057-1098. http://dx.doi.org/10.1016/S1473-3099(13)70318-9.
20. Rolain JM. 2013. Food and human gut as reservoirs of transferable antibiotic resistance encoding genes. Front Microbiol 4:173. http://dx.doi.org/10.3389/fmicb.2013.00173.
21. Chen MZ, Hsueh PR, Lee LN, Yu CJ, Yang PC, Luh KT. 2001. Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest 120:1072-1077. http://dx.doi.org/10.1378/chest.120.4.1072.
22. Ong CWM, Lye DCB, Khoo KL, Chua GSW, Yeoh SF, Leo YS, Tambyah PA, Chua AC. 2009. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific. Respirology 14:1200-1205. http://dx.doi.org/10.1111/j.1440-1843.2009.01630.x.
23. Mirza TA, Fillimban A, Maimini O, Khiyat EY, Dhafar KO, Farooq MU, Gazzaz ZJ. 2011. Predictors of asthma severity during the pilgrimage to Mecca (Hajj). Pol Arch Med Wewn 121:327-331.
24. Griffin DW. 2007. Atmospheric movement of microorganisms in clouds of desert dust and implications for human health. Clin Microbiol Rev 20:459-477. http://dx.doi.org/10.1128/CMR.00039-06.
25. Gautret P, Benkouiten S, Griffiths K, Sridhar S. 2015. The inevitable Hajj cough: surveillance data in French pilgrims, 2012-2014. Travel Med Infect Dis 33:485-489. http://dx.doi.org/10.1016/j.tmaid.2015.09.008.
26. OXA-72 in Taiwan. BMC Infect Dis 13:319. http://dx.doi.org/10.1186/1471-2334-13-319.
27. Memish ZA, Assiri A, Almasri M, Roshdy H, Hathout H, Kaase M, Gatermann SG, Yezli S. 2015. Molecular characterization of carbapenemase production among gram-negative bacteria in Saudi Arabia. Microb Drug Resist 21:307-314. http://dx.doi.org/10.1089/mdr.2014.0121.
28. Eveillard M, Kempf M, Belmonte O, Pailhoriès H, Joly-Guillou ML. 2013. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis 17:e802-e805. http://dx.doi.org/10.1016/j.ijid.2013.03.021.
29. Zenati K, Touati A, Bakour S, Sahli F, Rolain JM. 2016. Characterization of NDM-1- and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria. J Hosp Infect 92:19-26. http://dx.doi.org/10.1016/j.jhin.2015.09.020.
30. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 5:e10034. http://dx.doi.org/10.1371/journal.pone.0010034.
31. Tomaschek F, Higgins PG, Stefanik D, Wisplinghoff H, Seifert H. 2016. Head-to-head comparison of two multi-locus sequence typing (MLST) schemes for characterization of Acinetobacter baumannii outbreak and sporadic isolates. PLoS One 11:e0153014. http://dx.doi.org/10.1371/journal.pone.0153014.
32. Hammerum AM, Hansen F, Olesen B, Struve C, Holzknecht BJ, Andersen PS, Thye A-M, Jakobsen L, Røder BL, Stegger M, Hansen DS. 2015. Investigation of a possible outbreak of NDM-5-producing ST16 Klebsiella pneumoniae among patients in Denmark with no history of recent travel using whole-genome sequencing. J Glob Antimicrob Resist 3:219-221. http://dx.doi.org/10.1016/j.jgar.2015.05.003.
33. Cho SY, Huh HJ, Baek JY, Chung NY, Ryu JG, Lee NY, Song J. 2015. Klebsiella pneumoniae co-producing NDM-5 and OXA-181 carbapenemases, South Korea. Emerg Infect Dis 21:1088-1089. http://dx.doi.org/10.3201/eid2106.150048.
34. Sassi A, Loucif L, Gupta SK, Dekhil M, Chettibi H, Rolain J-M. 2014. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob Agents Chemother 58:5606-5608. http://dx.doi.org/10.1128/AAC.02818-13.
35. Rahman M, Shukla SK, Prasad KN, Ovejero CM, Pati BK, Tripathi A, Singh A, Srivastava AK, Gonzalez-Zorn B. 2014. Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India. Int J Antimicrob Agents 44:30-37. http://dx.doi.org/10.1016/j.ijantimicag.2014.03.003.
36. Hornsey M, Phee L, Wareham DW. 2011. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 55:5952-5954. http://dx.doi.org/10.1128/AAC.05108-11.
37. Balm MND, La M-V, Krishnan P, Jureen R, Lin RTP, Teo JWP. 2013. Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases. Clin Microbiol Infect 19:E421-E423. http://dx.doi.org/10.1111/1469-0691.12247.
38. Nakano R, Nakano A, Hikosaka K, Kawakami S, Matsunaga N, Asahara M, Ishigaki S, Furukawa T, Suzuki M, Shibayama K, Ono Y. 2014. First report of metallo-β-lactamase NDM-5-producing Escherichia coli in Japan. Antimicrob Agents Chemother 58:7611-7612. http://dx.doi.org/10.1128/AAC.04265-14.
39. NDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrob Agents Chemother 58:7548-7552. http://dx.doi.org/10.1128/AAC.03911-14.
40. NDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain. Antimicrob Agents Chemother 59:659-662. http://dx.doi.org/10.1128/AAC.04040-14.
41. Hammerum AM, Littauer P, Hansen F. 2015. Detection of Klebsiella pneumoniae co-producing NDM-7 and OXA-181, Escherichia coli producing NDM-5 and Acinetobacter baumannii producing OXA-23 in a single patient. Int J Antimicrob Agents 46:597-598. http://dx.doi.org/10.1016/j.ijantimicag.2015.07.008.
42. Zhang L-P, Xue W-C, Meng D-Y. 2016. First report of New Delhi metallo-β-lactamase 5 (NDM-5)-producing Escherichia coli from blood cultures of three leukemia patients. Int J Infect Dis 42:45-46. http://dx.doi.org/10.1016/j.ijid.2015.10.006.
43. Bathoorn E, Rossen JW, Lokate M, Friedrich AW, Hammerum AM. 2015. Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutch patient without travel history abroad, August 2015. Euro Surveill 20(41):pii=30040. http://dx.doi.org/10.2807/1560-7917.ES.2015.20.41.30040.
44. Chen D, Gong L, Walsh TR, Lan R, Wang T, Zhang J, Mai W, Ni N, Lu J, Xu J, Li J. 2016. Infection by and dissemination of NDM-5-producing Escherichia coli in China. J Antimicrob Chemother 71:563-565. http://dx.doi.org/10.1093/jac/dkv352.
45. Yousfi M, Mairi A, Bakour S, Touati A, Hassissen L, Hadjadj L, Rolain J-M. 2015. First report of NDM-5-producing Escherichia coli ST1284 isolated from dog in Bejaia, Algeria. New Microbes New Infect 8:17-18. http: //dx.doi.org/10.1016/j.nmni.2015.09.002.